IRVINE, Calif.--(BUSINESS WIRE)--With the U.S. House of Representatives expected to vote this week on legislation that would ease restrictions on embryonic stem cell research and fund alternatives, PrimeCell™ Therapeutics’ lead stem cell researcher, Francisco Silva, is available to discuss the company’s groundbreaking research in the development of adult germ line stem cells.
